Supported by Opella
Chair(s)
Mr Lars-Åke Söderlund, Co-chair, FIP Technology Advisory Group, Sweden
Introduction:
Join us at our Symposium: “From Shelf to Gut – The Critical Variables That Influence Probiotic Benefits”
In this engaging and interactive session moderated by
Prof. Lars Söderlund, we will delve into the fascinating world of probiotics, exploring how
manufacturing quality is a key determinant of their
efficacy.
Prof. Dr Mazzantini will share valuable insights about the science behind probiotics and her latest research on probiotics quality and survivability to gastrointestinal conditions led in the University of Pisa.
This is a unique opportunity to deepen your understanding of these complex products and to learn why maintaining
high-quality standards throughout their production is essential to delivering health benefits.
Programme:
| 12:45 – 12:50 | Opella – Health in Your Hands |
| Josephine Fubara, Science Chief Officer, Opella, USA | |
| 12:50 – 12:55 | Opening session and speaker introduction |
| Mr Lars-Åke Söderlund, Co-chair, FIP Technology Advisory Group, Sweden | |
| 12:55 – 12:58 | Quiz – Probiotics characteristics |
| Prof Dr Diletta Mazzantini, Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa, Italy | |
| 12:58 – 13:30 | From shelf to gut: The critical variables that influence probiotic benefits |
| Prof Dr Diletta Mazzantini, Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa, Italy | |
| 13:30 – 13:40 | Q&A |
| All panel | |
| 13:40 – 13:45 | Key observations and closing remarks |
| Mr Lars-Åke Söderlund, Co-chair, FIP Technology Advisory Group, Sweden | |
Learning objectives:
- Understand the key quality parameters that influence the efficacy of probiotics from production to consumption.
- Identify critical characteristics to evaluate when selecting probiotic products for responsible recommendation.
Take home messages:
- The quality of probiotics is crucial for their efficacy
- The quality parameters (safety, identity and purity, viability and potency) should drive the selection of a probiotic
- Probiotics possess functional properties that are essential for their survival, and therefore their efficacy, during storage and when administered to the consumers
- Probiotics are not all the same
